Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel.
about
Perioperative and Palliative Chemotherapy for Esophageal CancerAdjuvant and/or neoadjuvant therapy for gastric cancer? A perspective reviewPerioperative chemotherapy in gastroesophageal cancer. A retrospective monocenter evaluation of 42 cases.ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancerPhase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer.Docetaxel, Cisplatin, and 5-Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma.Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care.Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial.Current and future treatment options for esophageal cancer in the elderly.Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO){dagger}.Neoadjuvant treatment of locally advanced esophageal and junctional cancer: the evidence-base, current key questions and clinical trials.Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy.The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase IPost-therapeutic response evaluation by a combination of endoscopy and CT scan in esophagogastric adenocarcinoma after chemotherapy: better than its reputation.Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosis.Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study.Diagnostik und Therapie des Magenkarzinoms
P2860
Q26753865-02FEEAFA-8B91-4FFA-BF84-224EF630D6C4Q28088619-577A5199-13AA-4E01-8F8A-353F4A3A88A6Q35346910-929FE7F5-8DEF-49EE-9892-F884DDA97807Q36082155-38C395E7-8D57-4224-A3C8-5240D917E786Q36671857-413D7437-3855-4DDD-9B35-AC2E01609254Q37236380-9FB30F13-83BF-4BCC-886E-740FBEE25610Q37429923-6FE3AFC2-4D38-4356-B4E4-4A6809B858C3Q38134835-E5330CEB-E06B-446D-A238-4F906E0907B5Q38377462-1C7728AA-E980-4136-B20A-D5EFFA599C3BQ38679483-7A609811-D257-423C-9799-AA0C3668B0CCQ39199654-613E7D4E-A656-430F-8F80-17238F3B57C6Q40282337-42970329-F6ED-4AE9-9BAF-94337E7C8656Q41202499-1776505C-5A89-4B16-B306-BF468A277022Q46837098-B85D9419-8689-4847-8C57-DD24AFB740F7Q47096384-052F848E-61D9-48C9-8F67-5F57B0F4295EQ53070391-77BBA7DE-C8B9-48C3-B31A-E2C78DBB0B2CQ53096881-E2494295-4D90-447B-A010-DEC2A526CFE1Q53496643-E7286687-4210-46E6-A2CD-A08FB59EA170Q54535242-7505DF03-36C1-446F-A79D-10007FCBB2D8Q54970947-4B4E628A-C680-43BC-98CD-6677B0A0FD99Q56656007-8F7C1EBE-39F3-4496-B8DC-52743AE8532D
P2860
Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Pathological complete remissio ...... il, oxaliplatin and docetaxel.
@en
Pathological complete remissio ...... il, oxaliplatin and docetaxel.
@nl
type
label
Pathological complete remissio ...... il, oxaliplatin and docetaxel.
@en
Pathological complete remissio ...... il, oxaliplatin and docetaxel.
@nl
prefLabel
Pathological complete remissio ...... il, oxaliplatin and docetaxel.
@en
Pathological complete remissio ...... il, oxaliplatin and docetaxel.
@nl
P2093
P2860
P356
P1476
Pathological complete remissio ...... il, oxaliplatin and docetaxel.
@en
P2093
Akin Atmaca
Claudia Pauligk
Elke Jäger
Frank Noack
Hans-Michael Altmannsberger
Hans-Peter Bruch
Nils Homann
Salah-Eddin Al-Batran
Thomas Werner Kraus
P2860
P304
P356
10.1002/IJC.26180
P577
2011-08-05T00:00:00Z